Page 76 - Demo

sionofaorticaneurysmsisreducedbypropranololinahypertensiveratmodelJVascSurg1994;20178–83296SinhaNDablaPKOxidativestressandantioxidantsinhypertension-acurrentreviewCurrHypertensRev2015;11(2)132–42297DeVallanceELiY,JurczakMJCifuentes-PaganoEPaganoPJTheRoleofNADPHOxidasesintheEtiologyofObesityandMetabolicSyndromeContributionofIndividualIsoformsandCellBiology AntioxidRedoxSignal2019;31(10)687-709298MoranJP,CohenL,GreeneJMetal.PlasmaascorbicacidconcentrationsrelateinverselytobloodpressureinhumansubjectsAmJClinNutr1993;57(2)213–17299NawrotTSStaessen JARoelsHAetal.Bloodpressureandbloodseleniumacross-sectionalandlongitudinalpopulationstudyEurHeartJ2007;28(5)628–33300BarriosV,CalderónANavarro-CidJLaheraV,RuilopeLMNacetylcysteinepotentiatestheantihypertensiveeffectof ACEinhibitorsinhypertensivepatientsBloodPress2002;11(4)235–39301OnYK,KimCHSohnDWetalImprovementofendothelialfunctionbyamlodipineandvitaminCinessentialhypertensionKoreanJInternMed2002;17(2)131–7302HajjarIMGeorgeV,SasseEAKocharMSArandomizeddoubleblindcontrolledtrialof vitaminCinthemanagementofhypertensionandlipidsAmJTher2002;9(4)289–93303JuraschekSP,GuallarEAppelLJMillerER3rdEffectsofvitaminCsupplementationonbloodpressureameta-analysisofrandomizedcontrolledtrialsAmJClinNutr2012;95(5)1079–88304GinterEVplyvvolnýchradikálovaantioxidantovnacievnustenuEffectoffreeradicalsandantioxidantonthevascularwallVnitrLek2000;46(6)354–9305AntoniadesC TousoulisD TentolourisC ToutouzasP,StefanadisCOxidative stressantioxidantvitaminsandatherosclerosisFrombasicresearchtoclinicalpracticeHerz2003;28(7)628–38306RodrigoRGuichardCCharlesRClinicalpharmacologyand therapeuticuseofantioxidantvitaminsFundamClinPharmacol2007;21(2)111–27307GoliaELimongelliGNataleF,etal.InflammationandcardiovasculardiseasefrompathogenesistotherapeutictargetCurrAtherosclerRep2014;16(9)435308ChungESPackerMLoKHFasanmadeAAWillerson JTAnti-TNFTherapy AgainstCongestiveHeartFailureInvestigatorsRandomizeddouble-blindplacebo-controlledpilot trialofinfliximabachimericmonoclonalantibody to tumornecrosis factor-alphainpatients withmoderate-to-severeheartfailureresultsoftheanti-TNFTherapyAgainstCongestiveHeartFailure(ATTACH)trialCirculation2003;107(25)3133-40309RidkerPMEverettBM Thuren T,etal.CANTOS TrialGroup AntiinflammatoryTherapywithCanakinumabforAtheroscleroticaneurysmformationismediatedbyIL-17andattenuatedbymesenchymalstemcelltreatmentCirculation2012;126(Suppl1)S38-45284LindemanJHAbdul-HussienHSchaapherderAF,VanBockelJHVonderThüsenJHRoelenDL,KleemannREnhancedexpressionandactivationofpro-inflammatory transcription factorsdistinguishaneurysmalfromatheroscleroticaortaIL-6-andIL-8-dominatedinflammatoryresponsesprevailinthehumananeurysmClinSci(Lond)2008;114(11)687-97285GolledgeAL,WalkerP,NormanPEGolledge JAsystematicreviewofstudiesexamininginflammationassociatedcytokinesinhumanabdominalaorticaneurysm samplesDis Markers2009;26(4)181-8286ZhouHF, YanHCannon JL,SpringerLEGreen JMPhamCTCD43-mediatedIFN-γproductionbyCD8+TcellspromotesabdominalaorticaneurysminmiceJImmunol2013;190(10)5078-85287StatherPWSidloffDADattaniNGokaniVJChokeESayersRDBown MJ Meta-analysisandmeta-regressionanalysisofbiomarkersforabdominalaorticaneurysmBrJSurg2014;101(11)1358-72288WangSK,GreenLAGutweinARetal.DescriptionofhumanAAAbycytokineandimmunecellaberrationscomparedtorisk-factormatchedcontrolsSurgery2018;164(2)354-8289KingVL,LinAY,KristoF,Anderson TJetal.Interferon-gammaandtheinterferon-induciblechemokineCXCL10protectagainstaneurysmformationandruptureCirculation2009;119(3)426-35290WangY,Ait-OufellaHHerbinOetal.TGF-betaactivityprotectsagainstinflammatoryaorticaneurysmprogressionandcomplicationsinangiotensinII-infusedmice JClinInvest2010;120(2)422-32291YanHZhouHF,AkkAHuY,SpringerLEEnnisTL,PhamCTNNeutrophilProteasesPromoteExperimentalAbdominalAorticAneurysm viaExtracellular TrapReleaseandPlasmacytoidDendriticCellActivationArteriosclerThrombVascBiol2016;36(8)1660-69292WilliamsBManciaGSpieringWetal.2018PracticeGuidelinesfor themanagementofarterialhypertensionof theEuropeanSocietyofHypertensionandtheEuropeanSocietyofCardiologyESH/ESCTaskForce for the Managementof ArterialHypertension JHypertens2018;36(12)2284-309293HackamDG ThiruchelvamDRedelmeierDA Angiotensin-convertingenzymeinhibitorsandaorticruptureapopulation-basedcase-controlstudyLancet2006;368(9536)659‐65294Oesterle ALaufsULiao JKPleiotropicEffectsofStatinson theCardiovascularSystemCircRes2017;120(1)229‐43295Slaiby JMRicciMAGadowskiGRHendleyEDPilcherDBExpan184ANALESRANFwwwanalesranfcomInterferon-stimulatedgene15acommonlinkofvasculardamageinhypertensionobesityandaorticaneurysms-MaríaGonzálezAmoryAnaBGarcíaRedondoAnRealAcadFarmVol88Nº2(2022)·pp149-185